OTARMENI

This brand name is authorized in United States.

Active ingredients

The drug OTARMENI contains one active pharmaceutical ingredient (API):

1
UNII P6ZNU67HPU - LUNSOTOGENE PARVEC
 

Intracochlear infusion of lunsotogene parvec results in expression of the OTOF gene primarily in inner hair cells (IHCs), which facilitates production of functional otoferlin protein and restores synaptic transmission to the auditory nerve as shown in animal studies in mice.
 
Read more about Lunsotogene parvec

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 OTARMENI Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 61755-062

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈